PropThink: ENDP’s Deep Discount Won’t Last; Upside Scenarios Are Icing On The Cake

[ACN Newswire] – By David MoskowitzShares of Endo Pharmaceuticals (NASDAQ:ENDP) are trading at a deep discount to other pharmaceutical companies, with the last dip in price coming on the heels of guidance at the company’s … more

View todays social media effects on LLY

View the latest stocks trending across Twitter. Click to view dashboard